Thanks to the upcoming technological advancement, the evolution of ‘virtual man’ would become a reality over a period for time to predict the effects of new drugs before they enter clinical trials.
As a result by the year 2020, drug research and development procedures are expected to be cut short by 66% which would make possible to cut costs in a major way and increase productivity significantly.
A Report to this effect has been published by Pricewaterhouse Coopers a leading Management Consultancy Firm. According to this Report, a major concern of Pharma Companies is the slow-down in the rate of new drugs reaching the markers despite a record spend by them on R&D. As the patents launched in 90’s would be expiring in the next few years, only four of world’s top ten companies are believed to be having enough products to fill the looming sales gap. Hence improving innovation and boosting productivity are more an imperative rather than desire.
It is in this context, the Computer generated virtual models of the hear and other organs are being generated to simulate the physiological effects of drugs and the results have so far been encouraging. The advantages of this are two fold as the clinical trial times could be reduced by 40% coupled with a reduction in the subjects required for clinical trials.
No doubt the new drugs have to be tested before they are approved by the ‘virtual man’ comes in handy in building up a much more complete picture before hand by which process companies save time and energy.
……